Clinical Trial Update: Pycnogenol for the Treatment of Lymphedema [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study sponsored by the University of Wisconsin, Madison testing Pycnogenol for lymphedema, with the study status li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphedema

Drugs mentioned

• Pycnogenol (French maritime pine bark extract (Pinus pinaster bark extract))

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Lymphedema | Phase 2 | Status: COMPLETED